Interaction Between Magnesium and Neostigmine or Sugammadex for the Reversal of a Rocuronium-induced Neuromuscular Block
Clinical trial NCT03497923 · COMPLETED
Trial details
- NCT number
- NCT03497923
- Sponsor
- Christoph Czarnetzki
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2023-04-12
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.